ARS Pharmaceuticals (NASDAQ:SPRY) Stock Quotes, Forecast and News Summary

Q: What sector and industry does ARS Pharmaceuticals (SPRY) operate in?

ARS Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ARS Pharmaceuticals Stock (NASDAQ: SPRY) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 1.15M
Day Range	- - -
52 Wk Range	4.64 - 18.51
Market Cap	$1.30B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	24.37%
Days to Cover	13.57

Recent News

ARS Pharmaceuticals Inks Licensing Pact For Neffy Allergic Reaction Treatment, Analyst Sees Further Stock Upside Despite 200% Surge In 2024

ALK and ARS Pharmaceuticals sign a deal giving ALK global rights to Neffy nasal spray outside key regions, targeting peak sales of around $400 million in anaphylaxis treatment.

Vandana Singh

ARS Pharmaceuticals, Inc. is on the Move, Here's Why the Trend Could be Sustainable

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the sustainability of a trend isn't easy.

Zacks

ARS Pharmaceuticals, Inc. Upgraded to Buy: Here's Why

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Sep

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.7

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 1.15M
Day Range	- - -
52 Wk Range	4.64 - 18.51
Market Cap	$1.30B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	24.37%
Days to Cover	13.57

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy ARS Pharmaceuticals (SPRY) stock?

You can purchase shares of ARS Pharmaceuticals (NASDAQ:SPRY) through any online brokerage.

View our list of the best stock brokerages

Who are ARS Pharmaceuticals (SPRY) competitors?

Other companies in ARS Pharmaceuticals’s space includes: Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT), Upstream Bio (NASDAQ:UPB), Syndax Pharmaceuticals (NASDAQ:SNDX) and Arcutis Biotherapeutics (NASDAQ:ARQT).

What is the forecast, or price target, for ARS Pharmaceuticals (SPRY) stock?

ARS Pharmaceuticals has a consensus price target of $22.00.

What is the current price for ARS Pharmaceuticals (SPRY)?

The stock price for ARS Pharmaceuticals (NASDAQ: SPRY) is $13.35 last updated November 20, 2024 at 5:14 PM EST.

Does ARS Pharmaceuticals (SPRY) pay a dividend?

There are no upcoming dividends for ARS Pharmaceuticals.

When is ARS Pharmaceuticals (NASDAQ:SPRY) reporting earnings?

ARS Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 13, 2024.

Is ARS Pharmaceuticals (SPRY) going to split?

There is no upcoming split for ARS Pharmaceuticals.

What sector and industry does ARS Pharmaceuticals (SPRY) operate in?

ARS Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

ARS Pharmaceuticals

ARS Pharmaceuticals (SPRY) Forecast